| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 128,685 | 114,205 | 114,233 | 94,787 | | Cost of Revenue | 84,050 | 73,084 | 77,711 | 61,942 | | | Gross Profit | 44,635 | 41,121 | 36,522 | 32,845 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,011 | 27,965 | 25,968 | 28,206 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,624 | 13,156 | 10,554 | 4,639 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 14,830 | 13,156 | 10,554 | 4,639 | | Interest Expense | (1,300) | 632 | 668 | 1,195 | | Income Before Tax | 16,130 | 12,524 | 9,886 | 3,444 | | Income Tax Expense | 94 | 5,246 | 3,893 | 1,015 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,036 | 7,278 | 5,993 | 2,429 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,036 | 7,278 | 5,993 | 2,429 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,036 | $7,278 | $5,993 | $2,429 |
|
0.01% Nasdaq 
Income Statement
